MedMira (Germany) Today
| 47M Stock | EUR 0.05 0 5.75% |
Performance2 of 100
| Odds Of DistressOver 79
|
MedMira is trading at 0.046 as of the 28th of November 2024. This is a 5.75 percent increase since the beginning of the trading day. The stock's lowest day price was 0.046. MedMira has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for MedMira are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America and the Caribbean, Europe, the Asia Pacific, and internationally. The company was founded in 1993 and is headquartered in Halifax, Canada. The company has 697.45 M outstanding shares. More on MedMira
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
MedMira Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. MedMira's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MedMira or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
MedMira (47M) is traded on Frankfurt Exchange in Germany and employs 4 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 62.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MedMira's market, we take the total number of its shares issued and multiply it by MedMira's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MedMira classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 697.45 M outstanding shares.
MedMira has accumulated about 20.61 K in cash with (1.88 M) of positive cash flow from operations.
Check MedMira Probability Of Bankruptcy
Ownership AllocationMedMira maintains a total of 697.45 Million outstanding shares. MedMira secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 70.39 % of MedMira outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MedMira Ownership Details
MedMira Risk Profiles
Although MedMira's alpha and beta are two of the key measurements used to evaluate MedMira's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.98 | |||
| Semi Deviation | 6.45 | |||
| Standard Deviation | 9.6 | |||
| Variance | 92.13 |
MedMira Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in MedMira without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
MedMira Corporate Management
Elected by the shareholders, the MedMira's board of directors comprises two types of representatives: MedMira inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MedMira. The board's role is to monitor MedMira's management team and ensure that shareholders' interests are well served. MedMira's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MedMira's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stewart McKelvey | Legal Counsel | Profile | |
| Markus Meile | Chief Officer | Profile | |
| Hermes Chan | CEO, CoFounder | Profile | |
| Kevin Jones | Head Marketing | Profile |
Other Information on Investing in MedMira Stock
MedMira financial ratios help investors to determine whether MedMira Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedMira with respect to the benefits of owning MedMira security.